Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06624293 · ClinicalTrials.gov registry record
Access BNP Clinical Enrollment Study
A clinical trial, sponsored by Beckman Coulter.
- Completed
- Registry status
- 1,100
- Enrollment target
NCT06624293 is a clinical trial that has completed, run by Beckman Coulter. The registered enrollment target is 1,100 participants.
The verdict
NCT06624293 has completed, sponsored by Beckman Coulter.
- COMPLETED
- Registry status
- 1,100 participants
- Enrollment target
Study Summary
The goal of this study is to collect blood from subjects with a suspicion of either new onset or worsened heart failure to be used for testing studies for a new product to aid in the diagnosis of heart failure.
Interventions
- DIAGNOSTIC_TEST BNP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,100 participants |
| Start Date | 2024-08-30 |
| Est. Completion | 2025-02-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06624293
The ClinicalTrials.gov registry entry for NCT06624293 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beckman Coulter, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BNP is the first listed.
NCT06624293 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06624293 about?
NCT06624293 is a clinical study titled "Access BNP Clinical Enrollment Study". The goal of this study is to collect blood from subjects with a suspicion of either new onset or worsened heart failure to be used for testing studies for a new product to aid in the diagnosis of heart failure.
What is the current status of trial NCT06624293?
This trial is currently completed. The enrollment target is 1,100 participants. The study started on 2024-08-30. Estimated completion is 2025-02-18.
What interventions are being tested in trial NCT06624293?
The interventions under investigation include: BNP (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06624293?
This trial is sponsored by Beckman Coulter, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.